Estimate Recalculated Nov 11, 2024 07:54AM EST
Robert J More has an estimated net worth of $9.93 Million. This is based on reported shares across multiple companies, which include Volcano Corp, Orexigen Therapeutics, Inc., IOMAI CORP, Allakos Inc., GLAUKOS Corp, Tyra Biosciences, Inc., Vanda Pharmaceuticals Inc., Vir Biotechnology, Inc., NUVASIVE INC, Sienna Biopharmaceuticals, Inc., NOVACEA INC, CADENCE PHARMACEUTICALS INC, SANTARUS INC, Somaxon Pharmaceuticals, Inc., and Northstar Neuroscience, Inc..
Robert J More's CIK is 0001207792
2007 was Robert J More's most active year for acquiring shares with 3 total transactions. Robert J More's most active month to acquire stocks was the month of April. 2021 was Robert J More's most active year for disposing of shares, totalling 29 transactions. Robert J More's most active month to dispose stocks was the month of February. 2019 saw Robert J More paying a total of $250,000.00 for 185,822 shares, this is the most they've acquired in one year. In 2021 Robert J More cashed out on 105,948 shares for a total of $6,639,548.10, their largest year based on trade value.
Attention insiders:Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!